Marvel Fusion launched wholly owned subsidiary Caelora to commercialize high-energy laser technology developed around its fusion program. The Munich-based company plans diode-pumped laser systems for fusion and scientific research, together with radiation-source applications in medical, industrial, and security markets.
GLOBAL IMAGING BRIEF
Analysis: Creating a dedicated subsidiary can separate product commercialization, customer development, and supply-chain scaling from the longer fusion-power timetable. The move may open nearer-term demand for laser sources, beam delivery, optics, cooling, controls, and metrology, although product readiness and market uptake remain to be demonstrated.
Original source
This brief is an original summary based on the cited public source.